171 related articles for article (PubMed ID: 29339171)
1. DNA methylation level of the neprilysin promoter in Alzheimer's disease brains.
Nagata K; Mano T; Murayama S; Saido TC; Iwata A
Neurosci Lett; 2018 Mar; 670():8-13. PubMed ID: 29339171
[TBL] [Abstract][Full Text] [Related]
2. Neprilysin deficiency alters the neuropathological and behavioral phenotype in the 5XFAD mouse model of Alzheimer's disease.
Hüttenrauch M; Baches S; Gerth J; Bayer TA; Weggen S; Wirths O
J Alzheimers Dis; 2015; 44(4):1291-302. PubMed ID: 25408216
[TBL] [Abstract][Full Text] [Related]
3. Oxidized neprilysin in aging and Alzheimer's disease brains.
Wang DS; Iwata N; Hama E; Saido TC; Dickson DW
Biochem Biophys Res Commun; 2003 Oct; 310(1):236-41. PubMed ID: 14511676
[TBL] [Abstract][Full Text] [Related]
4. Amyloid Beta-Mediated Hypomethylation of Heme Oxygenase 1 Correlates with Cognitive Impairment in Alzheimer's Disease.
Sung HY; Choi BO; Jeong JH; Kong KA; Hwang J; Ahn JH
PLoS One; 2016; 11(4):e0153156. PubMed ID: 27058954
[TBL] [Abstract][Full Text] [Related]
5. The epigenetic effects of amyloid-beta(1-40) on global DNA and neprilysin genes in murine cerebral endothelial cells.
Chen KL; Wang SS; Yang YY; Yuan RY; Chen RM; Hu CJ
Biochem Biophys Res Commun; 2009 Jan; 378(1):57-61. PubMed ID: 19007750
[TBL] [Abstract][Full Text] [Related]
6. No association between polymorphisms in the neprilysin promoter region and Swedish Alzheimer's disease patients.
Lilius L; Forsell C; Axelman K; Winblad B; Graff C; Tjernberg L
Neurosci Lett; 2003 Feb; 337(2):111-3. PubMed ID: 12527400
[TBL] [Abstract][Full Text] [Related]
7. Altered CpG methylation in sporadic Alzheimer's disease is associated with APP and MAPT dysregulation.
Iwata A; Nagata K; Hatsuta H; Takuma H; Bundo M; Iwamoto K; Tamaoka A; Murayama S; Saido T; Tsuji S
Hum Mol Genet; 2014 Feb; 23(3):648-56. PubMed ID: 24101602
[TBL] [Abstract][Full Text] [Related]
8. Recombinant soluble neprilysin reduces amyloid-beta accumulation and improves memory impairment in Alzheimer's disease mice.
Park MH; Lee JK; Choi S; Ahn J; Jin HK; Park JS; Bae JS
Brain Res; 2013 Sep; 1529():113-24. PubMed ID: 23831521
[TBL] [Abstract][Full Text] [Related]
9. Neprilysin degrades murine Amyloid-β (Aβ) more efficiently than human Aβ: Further implication for species-specific amyloid accumulation.
Becker M; Moore A; Naughton M; Boland B; Siems WE; Walther T
Neurosci Lett; 2018 Nov; 686():74-79. PubMed ID: 30144539
[TBL] [Abstract][Full Text] [Related]
10. Glia-specific APOE epigenetic changes in the Alzheimer's disease brain.
Tulloch J; Leong L; Thomson Z; Chen S; Lee EG; Keene CD; Millard SP; Yu CE
Brain Res; 2018 Nov; 1698():179-186. PubMed ID: 30081037
[TBL] [Abstract][Full Text] [Related]
11. Cerebrospinal fluid neprilysin is reduced in prodromal Alzheimer's disease.
Maruyama M; Higuchi M; Takaki Y; Matsuba Y; Tanji H; Nemoto M; Tomita N; Matsui T; Iwata N; Mizukami H; Muramatsu S; Ozawa K; Saido TC; Arai H; Sasaki H
Ann Neurol; 2005 Jun; 57(6):832-42. PubMed ID: 15929037
[TBL] [Abstract][Full Text] [Related]
12. Dinucleotide repeat polymorphisms in the neprilysin gene are not associated with sporadic Alzheimer's disease.
Oda M; Morino H; Maruyama H; Terasawa H; Izumi Y; Torii T; Sasaki K; Nakamura S; Kawakami H
Neurosci Lett; 2002 Mar; 320(1-2):105-7. PubMed ID: 11849775
[TBL] [Abstract][Full Text] [Related]
13. Association of the Neprilysin gene with susceptibility to late-onset Alzheimer's disease.
Sakai A; Ujike H; Nakata K; Takehisa Y; Imamura T; Uchida N; Kanzaki A; Yamamoto M; Fujisawa Y; Okumura K; Kuroda S
Dement Geriatr Cogn Disord; 2004; 17(3):164-9. PubMed ID: 14739539
[TBL] [Abstract][Full Text] [Related]
14. Age-dependent decline of neprilysin in Alzheimer's disease and normal brain: inverse correlation with A beta levels.
Hellström-Lindahl E; Ravid R; Nordberg A
Neurobiol Aging; 2008 Feb; 29(2):210-21. PubMed ID: 17098332
[TBL] [Abstract][Full Text] [Related]
15. Association between neprilysin polymorphisms and sporadic Alzheimer's disease.
Wood LS; Pickering EH; McHale D; Dechairo BM
Neurosci Lett; 2007 Nov; 427(2):103-6. PubMed ID: 17928142
[TBL] [Abstract][Full Text] [Related]
16. CpG and non-CpG Presenilin1 methylation pattern in course of neurodevelopment and neurodegeneration is associated with gene expression in human and murine brain.
Monti N; Cavallaro RA; Stoccoro A; Nicolia V; Scarpa S; Kovacs GG; Fiorenza MT; Lucarelli M; Aronica E; Ferrer I; Coppedè F; Troen AM; Fuso A
Epigenetics; 2020 Aug; 15(8):781-799. PubMed ID: 32019393
[TBL] [Abstract][Full Text] [Related]
17. Impact of Insulin Degrading Enzyme and Neprilysin in Alzheimer's Disease Biology: Characterization of Putative Cognates for Therapeutic Applications.
Jha NK; Jha SK; Kumar D; Kejriwal N; Sharma R; Ambasta RK; Kumar P
J Alzheimers Dis; 2015; 48(4):891-917. PubMed ID: 26444774
[TBL] [Abstract][Full Text] [Related]
18. Polymorphisms in neprilysin gene affect the risk of Alzheimer's disease in Finnish patients.
Helisalmi S; Hiltunen M; Vepsäläinen S; Iivonen S; Mannermaa A; Lehtovirta M; Koivisto AM; Alafuzoff I; Soininen H
J Neurol Neurosurg Psychiatry; 2004 Dec; 75(12):1746-8. PubMed ID: 15548496
[TBL] [Abstract][Full Text] [Related]
19. Anti-amyloid activity of neprilysin in plaque-bearing mouse models of Alzheimer's disease.
Mohajeri MH; Kuehnle K; Li H; Poirier R; Tracy J; Nitsch RM
FEBS Lett; 2004 Mar; 562(1-3):16-21. PubMed ID: 15043995
[TBL] [Abstract][Full Text] [Related]
20. A combination Alzheimer's therapy targeting BACE1 and neprilysin in 5XFAD transgenic mice.
Devi L; Ohno M
Mol Brain; 2015 Mar; 8():19. PubMed ID: 25884928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
